Medicinal cannabis company Australian Natural Therapeutics Group (ANTG) has been granted the green light to ship its locally cultivated product to New Zealand.
And for the first time, New Zealanders can request access to medicinal cannabis dried flower.
The Eve CBD flower will be accessed through New Zealand’s largest medicinal cannabis distributor, NUBU Pharmaceuticals, which has also been instrumental in brokering this historic arrangement.
ANTG Chief Executive Officer, Matthew Cantelo, said this is a landmark deal for both countries.
“This agreement is not only a historic first for New Zealand, but also beneficial for the Australian industry as a whole,” said Mr Cantelo.
Best in the world
“The high benchmarks in Australia for growing and producing medicinal cannabis has set us up as the best in the world,” he said.
“We have a reputation and climate for growing excellent produce in general – it makes sense that we would produce the highest quality medicinal cannabis product as well.”
“Our Kiwi neighbours will also have access to the highest quality Australian flower while their home-grown cultivation industry starts producing.”
ANTG’s growing and manufacturing facility complies with international quality standards (GACP and GMP), securing the gold standard in growing and manufacturing medicinal cannabis.
NZ patients welcome new agreement
Co-Founder & CEO of NUBU Pharmaceuticals, Mark Dye, says patients will be the big winners following the agreement.
“They have been calling out for this for decades,” said Mr Dye. “I am so proud it is the team at NUBU that has been able to make this happen for them.”
“ANTG are very much leading the Australasian cannabis industry. We are over the moon to have them as a distribution partner.”
ANTG Eve dried flower is for preparation of tea for oral consumption.
Formed in 2015, ANTG now produces four strains of medicinal cannabis flower and has just started production of four oil combinations. It also partners with research organisations including the University of Newcastle and University of Western Sydney, to unlock the potential of cannabis in the fight against cancer, dementia, inflammation and chronic pain.
Formed in 2016, NUBU Pharmaceuticals is New Zealand’s largest medicinal cannabis distribution company.
NUBU brings medicinal cannabis products and medical devices to New Zealand, distributing them via partnerships with all the country’s pharmacy networks.
The company also develops New Zealand-made cannabis products for export markets.